Accumetrics, Inc. (Accumetrics) has signed new distribution agreements for its VerifyNow System in several European countries. Distribution of Accumetrics’ VerifyNow products will be handled by AAZ in France, BITmedical GmbH in both Austria and Switzerland and Kordia in the Netherlands, Belgium and Luxembourg. The VerifyNow System assesses response to life-saving antiplatelet therapies, such as aspirin, Plavix and GP IIb/IIIa inhibitors.
As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet medications are receiving the optimal benefit.
“We’re extremely excited to continue with the global expansion of our distribution strategy for the VerifyNow System. Accumetrics has chosen each of these partners based on their demonstrated expertise and knowledge of our markets in their respective territories,” said Timothy I. Still, president and chief executive officer.
“These partnerships demonstrate our ongoing expansion of our distribution channels outside the United States, and support our vision to provide physicians access to critical information for managing their cardiovascular patients on antiplatelet therapies.”